Jacquelyn Meyers Jacquelyn Meyers Jacquelyn Meyers Jacquelyn Meyers Jacquelyn Meyers Jacquelyn Meyers Jacquelyn Meyers Jacquelyn Meyers
Jacquelyn L. Meyers, PhD
I have advanced level training in psychiatric epidemiology and genomics (focus: traumatic stress and substance use disorders) and extensive research experience in neurocognitive markers of addiction. This has culminated in the interdisciplinary program of research I lead at SUNY Downstate Medical Center, examining the confluence of psycho-social, genetic, and neurodevelopmental risk factors for substance use disorders in diverse populations.
RECENT RESEARCH
Findings from recent study published in Molecular Psychiatry provide support for the role of genetic variants on chromosome 18q23 in regulating neural connectivity and alcohol use behavior, potentially via dysregulated myelination. These novel genetic findings highlight the importance of including populations of diverse ancestry in genetics research on Substance Use Disorders and the utility of the neurophysiological data in enhancing our understanding of mechanisms underlying addiction susceptibility.
Latest research from the Collaborative Study on the Genetics of Alcoholism found that exposure to traumatic life events increases the impact of polygenic risk on cannabis use and disorders and demonstrates that ignoring important aspects of the psychosocial environment may mask genetic influences on polygenic traits. Results are published online in Translational Psychiatry .
Other work from Collaborative Study on the Genetics of Alcoholism has supported the hypothesis that changes in neurocognitive development related to early sexual trauma exposure could increase the risk for mental health and substance use problems in young adulthood. Results are published online in the Journal of the American Academy of Child and Adolescent Psychiatry.
